SNN: Smith & Nephew plc
Performance
Watchlist
Select an item
Summary
SNN at a glance
SNN returned -4.02% over the past year and -0.87% a year over five years. Its worst drop in that year was -26.88%, smaller than 65% of stocks on Redstone, and its Sharpe ratio of -0.15 beats 21% of stocks on Redstone. It yields 2.56%.
Current Drawdown
-13.56%
Rolling Volatility
39.13%
Dividends
SNN dividends
Yield
2.56%
Paid, past year
$0.79
Pays
Twice a year
Growth a year
+0.5%
Per share, by year
Yearly return over 5 years
SNN paid $0.79 a share over the past year, twice a year. Its yearly rate rose from $0.75 in 2022 to $0.76 in 2025, 0.5% a year. With dividends reinvested it returned -0.87% a year over five years, against -3.51% on price alone.
›All 10 payments since Mar 31, 2022
- Oct 2, 2026$0.312
- Mar 27, 2026$0.482
- Oct 3, 2025$0.30
- Mar 28, 2025$0.462
- Oct 4, 2024$0.288
- Apr 1, 2024$0.462
- Oct 5, 2023$0.288
- Mar 30, 2023$0.462
- Sep 29, 2022$0.288
- Mar 31, 2022$0.462
Metrics
Risk Indicators
Profile
About SNN
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT.
- Sector
- Health Care
- Market cap
- $13.0B
- Listed
- Nov 1999
- Employees
- 17,000
- Website
- smith-nephew.com
Comparisons